Welcome to DTx Equals, the show where thought-leaders in digital therapeutics put a stake in the ground about what makes DTx, DTx.

Our Guest Today: Simon Thomas, President at Freespira

What you'll get out of this episode:

• What's a formative event in your life or career that influenced your path in DTX?
• Observations on the ways that FDA is now working with companies now to demonstrate the clinical viability of their product. And any thoughts about how that how that has evolved over time?
• DTX equals what? What's kind of the most defining issue in DTX today from where you're standing?
• What's the relative role of automated technology versus having that human element in terms of achieving the best clinical outcomes?
• Is the goal to basically leave the coach to do the things once everything is automated that can be to do, or is the idea that ultimate technology will catch up to mimicking what a coach does?
• What's something DTX will be able to do in the future that I can't do today?
• What's the gap between in-person interactions and mimicking it in technology that makes it so hard?

To learn more about Simon Thomas and Freespira please use the links below:

- Simon's LinkedIn - Freespira LinkedIn - Freespira Website

Also, be sure to follow DTx Equals on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter